A ray of light for patients with inflammatory bowel disease: Vedolizumab success story in a patient with ulcerative colitis

IBD is a chronic condition that requires lifetime therapy, the safety and tolerability profile of vedolizumab is suitable for long-term treatment to maintain or improve the quality of life in patients with moderate-to-severely active UC.